FRM
AXSM icon

Fox Run Management’s Axsome Therapeutics AXSM Stock Holding History

Fox Run Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,584
Closed -$1.58M – 865
2025
Q1 		$1.58M Buy
13,584
+7,465
+122% +$850K 0.25% 69
2024
Q4 		$518K Buy
+6,119
New +$563K 0.09% 427
2023
Q4 		– Sell
-5,250
Closed -$367K – 731
2023
Q3 		$367K Buy
+5,250
New +$392K 0.11% 365
2023
Q1 		– Sell
-3,416
Closed -$263K – 653
2022
Q4 		$263K Sell
3,416
-2,451
-42% -$147K 0.11% 389
2022
Q3 		$262K Buy
+5,867
New +$293K 0.1% 396
2021
Q2 		– Sell
-3,797
Closed -$215K – 341
2021
Q1 		$215K Buy
+3,797
New +$267K 0.39% 158

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return